NCT01874951 - Low-Dose Naltrexone (LDN) for Depression Relapse and Recurrence | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions

Major Depressive DisorderDepression, UnipolarRecurrenceRelapse

Interventions

DRUG

Naltrexone

1 mg of naltrexone will be given twice daily to all patients assigned to active drug.

DRUG

Placebo

Placebo identical in appearance to naltrexone will be given twice daily to all patients assigned to placebo.

Trial Locations (1)

Massachusetts General Hospital; Depression Research and Clinical Program, Boston